Edgewise Share Price

Edgewise Share Price

NASDAQ: EWTX | Mid Cap | Healthcare
$39.88
-$1.23 (-2.99%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Edgewise Stock Performance

Open
$40.64
Prev. Close
$41.12
Circuit Range
N/A
Day Range
$39.79 - $41.41
Year Range
$19.80 - $48.59
Volume
48,866
Average Traded
$40.24

Edgewise Share Price Today

As of 22 November 2026, Edgewise Therapeutics, Inc.'s share price is $39.88. The stock opened at $40.64, compared to its previous close of $41.12. During today's trading session, Edgewise Therapeutics, Inc.'s share price traded between $39.79 and $41.41, with an average price of $40.60. Over the past 52 weeks, the stock has recorded a high of $48.59 and a low of $19.80. In terms of performance, Edgewise Therapeutics, Inc.'s share price has risen by 16.78% over the last six months and is up 52.99% on a year-on-year basis.

Edgewise Share Price Chart

Line chart of the Edgewise price trend over the selected period. The price fell overall, ranging from 39.79 to 41.41, ending at 39.88.
$39.79$41.41
L
Show Current Price
H

Edgewise Stock Fundamentals & Key Indicators

Market Cap
$4.11B
PE Ratio (TTM)
4.33
Dividend Yield
0.00%
EPS (TTM)
$9.22
Revenue (TTM)
$0.00
Return On Equity (TTM)
61.84%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
2422.08%

Edgewise Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$50.22-$49.01-$57.33$1166.15
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A2.41%-16.98%2134.10%

Edgewise Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$67.64-$100.16-$133.81-$167.80
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-48.08%-33.60%-25.40%

Edgewise Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets9.2211.3313.0410.1
Current Assets543.39475.48327.0357.0
Total Assets552.6486.82340.04367.1
Non Current Liabilities2.983.744.433.8
Current Liabilities27.3723.8616.7716.59
Total Liabilities30.3527.621.2120.39
Shareholders' Equity522.26459.22318.83346.72

Edgewise Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-143.82-109.03-91.95-52.64
Investing-32.79-184.66102.89-70.58
Financing196.09249.2553.17129.64

About Edgewise

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The company's product candidates are Sevasemten, EDG-7500, EDG-003, and EDG-15400. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies, including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company's products are currently in different stages of their development, being developed to target key muscle proteins and modulators to address a broad array of muscle diseases.

Edgewise Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$39.49
$39.83
+2.17%
Oct 2026
$40.88
$38.98
-4.25%
Sep 2026
$41.82
$40.71
-7.98%
Aug 2026
$38.48
$44.24
+15.12%
Jul 2026
$40.97
$38.43
-5.41%
Jun 2026
$40.53
$40.63
+18.96%
May 2026
$30.80
$34.16
+10.32%
Apr 2026
$32.63
$30.96
-1.68%
Mar 2026
$30.07
$31.49
+3.47%
Feb 2026
$28.13
$30.43
+8.10%
Jan 2026
$25.08
$28.16
+13.51%
Dec 2025
$26.08
$24.80
-4.85%

Edgewise Share Price FAQs